About Limbus AI
Limbus AI is a company based in Regina (Canada) founded in 2017 by Joshua Giambattista was acquired by Radformation in May 2024. It operates as a AI-as-a-Service. Limbus AI offers products and services including Limbus Contour. Limbus AI operates in a competitive market with competitors including Manteia technology, Vision RT, Applied Computational Technologies, Virtual Phantoms and Radiopharmaceutical Imaging and Dosimetry, among others.
- Headquarter Regina, Canada
- Founders Joshua Giambattista
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Limbus Ai
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Radformation
(May 01, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Limbus AI
Limbus AI offers a comprehensive portfolio of products and services, including Limbus Contour.
Automated contouring software for radiation therapy planning.
People of Limbus AI
Unlock access to complete
Funding Insights of Limbus AI
Detailed funding history for Limbus AI
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Limbus AI
Limbus AI has secured backing from 1 investor. Prominent investors backing the company include Radformation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Decision support technologies for radiation therapy planning are developed.
|
Locked | Locked | Locked |
Investor details for Limbus AI
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Limbus AI
Investment portfolio details for Limbus AI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Limbus AI
Detailed financials for Limbus AI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Limbus Ai Comparisons
Peer comparison for Limbus AI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Limbus AI
Limbus AI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Manteia technology, Vision RT, Applied Computational Technologies, Virtual Phantoms and Radiopharmaceutical Imaging and Dosimetry, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Adaptive radiotherapy system for disease diagnosis is provided.
|
|
| Locked | Locked | Locked |
Optical guidance technologies are developed to enhance radiological imaging quality.
|
|
| Locked | Locked | Locked |
Radiation dose calculation software for cancer treatment is developed.
|
|
| Locked | Locked | Locked |
Radiation dose calculations are enabled via virtual phantom software.
|
|
| Locked | Locked | Locked |
Quantitative imaging and dosimetry software is developed for radiopharmaceutical therapy.
|
|
| Locked | Locked | Locked |
Provides 3D printed replicas for radiotherapy treatment verification.
|
Detailed competitors of Limbus AI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Limbus Ai
Complete news archive for Limbus AI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Limbus AI
Limbus AI was founded in 2017.
Limbus AI is headquartered in Regina, Canada. It is registered at Regina, Saskatchewan, Canada.
Joshua Giambattista is the current CEO of Limbus AI. They have also founded this company.
Limbus AI is focused on delivering AI-driven solutions for radiation therapy through its flagship product, Limbus Contour. Automated contouring for clinical-grade structures is offered, supporting treatment planning systems with secure, local data processing. The healthcare sector, specifically cancer care, is served by integrating deep learning technology to enhance workflow efficiency. Solutions are designed to reduce contouring time significantly, ensuring compatibility with existing clinical workstations without cloud dependency. Comprehensive research and clinical validation back the technology, ensuring reliability across various anatomical sites.
Limbus AI's top competitors include Vision RT, Manteia technology and Virtual Phantoms.
Limbus AI offers Limbus Contour.
Limbus AI has 1 investor. Key investors include Radformation.